Related Articles
Cutaneous melanoma and the immunotherapy revolution (Review)
Opportunities and challenges of co‑targeting epidermal growth factor receptor and autophagy signaling in non‑small cell lung cancer (Review)
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)
Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review)
Immunotherapy in malignant peritoneal mesothelioma (Review)